Naturhouse Health, S.A. (NTH.MC)
Madrid, ES
Naturhouse Health, S.A. is a prominent entity in the global nutrition and weight management sector, maintaining a significant presence across Spain, Italy, France, Poland, and numerous other international markets. The company provides a diverse array of offerings, including food supplements crafted from natural botanical extracts, which are designed to enhance nutrient intake. Additionally, it supplies a variety of specialized dietetic foods and beverages, such as breakfast items, snacks, and meal replacement solutions. Expanding its portfolio, Naturhouse also offers cosmetics and body care products. This line features beauty preparations specifically formulated for skincare during the slimming process, addressing concerns like cellulite and promoting skin firmness, alongside anti-aging treatments. By the end of 2020, its substantial international footprint encompassed 1,788 centers located in 28 countries. These products are distributed to consumers through a network comprising both company-owned and franchised Naturhouse outlets. Established in 1991 and headquartered in Madrid, Spain, the company was previously recognized as Housediet, S.L.U.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.19% | +0.39% | +0.79% | -0.78% | +20.85% | +15.91% | +42.46% | +46.55% | +50.00% | -36.25% | -48.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-09 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%-3.6% Q2'25: -5.8% (vs Q2'24)
-
EPS growth Packaged Foods: +14.6%+6.3% Q2'25: +2.9% (vs Q2'24)
-
FCF margin FCF growth · Packaged Foods: +15.9%+21.4% Q2'25: +27.7% (vs Q2'24)
-
EBIT margin Packaged Foods: +7.9%+28.0% ★ Q2'25: +31.0% (vs Q2'24)
-
ROIC Packaged Foods: +7.0%+150.0% ★ Q2'25: +231.9% (vs Q2'24)
-
Share dilution Packaged Foods: +0.0%-1.0% ★ Q2'25: +0.0% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.23× ★ Q2'25: 0.16× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
95.79M
est: 97.10M (-1.3%)
|
97.82M
est: 100.20M (-2.4%)
|
94.70M
est: 96.71M (-2.1%)
|
87.29M
est: 87.05M (+0.3%)
|
81.67M
est: 83.38M (-2.1%)
|
55.08M
est: 67.00M (-17.8%)
|
57.59M
est: 59.80M (-3.7%)
|
52.40M
est: 56.70M (-7.6%)
|
50.41M
est: 45.50M (+10.8%)
|
49.43M
est: 50.00M (-1.2%)
|
47.63M
est: 48.80M (-2.4%)
|
48.10M
48.10M – 48.10M
-1.4% YoY
|
47.60M
47.60M – 47.60M
-1.0% YoY
|
| EBITDA |
34.56M
est: 31.83M (+8.6%)
|
33.22M
est: 32.84M (+1.1%)
|
29.85M
est: 31.70M (-5.8%)
|
23.90M
est: 28.53M (-16.2%)
|
23.54M
est: 27.33M (-13.9%)
|
16.96M
est: 21.96M (-22.8%)
|
20.80M
est: 19.60M (+6.1%)
|
15.61M
est: 18.59M (-16.0%)
|
17.94M
est: 14.91M (+20.3%)
|
15.63M
est: 16.34M (-4.4%)
|
14.45M
est: 15.95M (-9.4%)
|
15.72M
15.72M – 15.72M
-1.4% YoY
|
15.56M
15.56M – 15.56M
-1.0% YoY
|
| EBIT |
33.42M
est: 27.36M (+22.2%)
|
32.22M
est: 28.23M (+14.1%)
|
28.75M
est: 27.25M (+5.5%)
|
22.79M
est: 24.53M (-7.1%)
|
19.25M
est: 23.49M (-18.1%)
|
13.70M
est: 18.88M (-27.4%)
|
18.35M
est: 16.85M (+8.9%)
|
13.31M
est: 15.98M (-16.7%)
|
15.67M
est: 12.82M (+22.2%)
|
13.68M
est: 14.40M (-5.0%)
|
13.31M
est: 14.05M (-5.3%)
|
13.85M
13.85M – 13.85M
-1.4% YoY
|
13.71M
13.71M – 13.71M
-1.0% YoY
|
| Net Income |
22.86M
est: 22.85M (+0.0%)
|
22.50M
est: 23.57M (-4.5%)
|
19.86M
est: 22.54M (-11.9%)
|
15.37M
est: 15.89M (-3.2%)
|
13.26M
est: 13.84M (-4.2%)
|
9.38M
est: 8.08M (+16.1%)
|
13.36M
est: 13.19M (+1.3%)
|
9.63M
est: 11.39M (-15.5%)
|
11.29M
est: 8.99M (+25.6%)
|
9.86M
est: 10.09M (-2.3%)
|
10.09M
est: 9.50M (+6.3%)
|
8.91M
8.91M – 8.91M
-6.3% YoY
|
8.91M
8.91M – 8.91M
+0.0% YoY
|
| SGA |
27.09M
est: 20.32M (+33.3%)
|
28.30M
est: 20.97M (+34.9%)
|
30.31M
est: 20.24M (+49.7%)
|
31.10M
est: 18.22M (+70.7%)
|
13.43M
est: 17.45M (-23.1%)
|
10.58M
est: 14.02M (-24.6%)
|
10.30M
est: 12.52M (-17.7%)
|
11.30M
est: 11.87M (-4.8%)
|
12.60M
est: 9.52M (+32.3%)
|
10.39M
est: 8.55M (+21.6%)
|
—
est: 8.34M (-100.0%)
|
8.22M
8.22M – 8.22M
-1.4% YoY
|
8.14M
8.14M – 8.14M
-1.0% YoY
|
| EPS |
0.38
est: 0.38 (-0.3%)
|
0.38
est: 0.39 (-3.4%)
|
0.33
est: 0.38 (-12.2%)
|
0.26
est: 0.27 (-1.9%)
|
0.22
est: 0.23 (-4.7%)
|
0.16
est: 0.13 (+18.7%)
|
0.22
est: 0.22 (+0.0%)
|
0.16
est: 0.19 (-15.8%)
|
0.19
est: 0.15 (+26.7%)
|
0.16
est: 0.17 (-5.9%)
|
0.17
est: 0.16 (+6.3%)
|
0.15
0.15 – 0.15
-6.3% YoY
|
0.15
0.15 – 0.15
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Felix Revuelta Fernandez | Executive Chairman & Chief Executive Officer | 1M | male |
| Alfonso Baron Bastarreche | Secretary of the Board of Directors | — | male |
| Enrique Yeste Alameda | Director of International Marketing | — | male |
| Frédéric Julien | Managing Director of France & Belgium | — | male |
| Mario Carrasco-Munoz Guerra | Head of Internal Audit | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NTH.MC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
